Overall survival and updated results for sunitinib compared with interferon alfa in patients with metastatic renal cell carcinoma.

Motzer RJ, Hutson TE, Tomczak P, Michaelson MD, Bukowski RM, Oudard S, Negrier S, Szczylik C, Pili R, Bjarnason GA, Garcia-del-Muro X, Sosman JA, Solska E, Wilding G, Thompson JA, Kim ST, Chen I, Huang X, Figlin RA
J Clin Oncol. 2009 27 (22): 3584-90

PMID: 19487381 · PMCID: PMC3646307 · DOI:10.1200/JCO.2008.20.1293

MeSH Terms (28)

Administration, Oral Adult Aged Carcinoma, Renal Cell Confidence Intervals Disease-Free Survival Dose-Response Relationship, Drug Drug Administration Schedule Female Follow-Up Studies Humans Indoles Injections, Subcutaneous Interferon-alpha Kaplan-Meier Estimate Kidney Neoplasms Male Maximum Tolerated Dose Middle Aged Neoplasm Invasiveness Neoplasm Metastasis Neoplasm Staging Probability Proportional Hazards Models Pyrroles Sunitinib Survival Analysis Treatment Outcome

Connections (1)

This publication is referenced by other Labnodes entities: